RSV-vaccine prices vary by country, insurer, and dose. Here’s a concise overview to help you gauge typical costs and coverage as of late 2025.

• Without insurance (out-of-pocket): commonly around $300–$550 USD per dose in many regions, with some markets showing roughly $350 on average. Availability of coupons or discounts can reduce the out-of-pocket amount in some cases.

• With insurance (including Medicare Part D in the U.S.): many plans cover the RSV vaccine and its administration with little to no out-of-pocket cost, though exact copays or deductibles can depend on the specific plan and provider. Coverage often results in $0–$20 out-of-pocket for the vaccine itself, sometimes with no charge for the administration.

• Regional variations: prices differ by country and clinical setting. For example, Denmark and other European markets may list RSV vaccine prices in local currency (e.g., around 1,900 DKK in some listings) with potential consultation or administration fees. Always verify with the local provider.

• Public programs and subsidized pricing: several countries maintain subsidy programs or pricing lists for certain groups (e.g., seniors, certain medical conditions) which can substantially lower or eliminate out-of-pocket costs. Check national health service guidance or your insurer for current eligibility and amounts.

If you want, I can tailor this to your location (country or state) and whether you have insurance, a Medicare plan, or are paying out-of-pocket, and I can pull the most relevant current figures for your situation.